265 related articles for article (PubMed ID: 32283114)
1. The MID1 gene product in physiology and disease.
Baldini R; Mascaro M; Meroni G
Gene; 2020 Jul; 747():144655. PubMed ID: 32283114
[TBL] [Abstract][Full Text] [Related]
2. MID1 catalyzes the ubiquitination of protein phosphatase 2A and mutations within its Bbox1 domain disrupt polyubiquitination of alpha4 but not of PP2Ac.
Du H; Wu K; Didoronkute A; Levy MV; Todi N; Shchelokova A; Massiah MA
PLoS One; 2014; 9(9):e107428. PubMed ID: 25207814
[TBL] [Abstract][Full Text] [Related]
3. The E3 ubiquitin ligase MID1/TRIM18 promotes atypical ubiquitination of the BRCA2-associated factor 35, BRAF35.
Zanchetta ME; Napolitano LMR; Maddalo D; Meroni G
Biochim Biophys Acta Mol Cell Res; 2017 Oct; 1864(10):1844-1854. PubMed ID: 28760657
[TBL] [Abstract][Full Text] [Related]
4. Mig12, a novel Opitz syndrome gene product partner, is expressed in the embryonic ventral midline and co-operates with Mid1 to bundle and stabilize microtubules.
Berti C; Fontanella B; Ferrentino R; Meroni G
BMC Cell Biol; 2004 Feb; 5():9. PubMed ID: 15070402
[TBL] [Abstract][Full Text] [Related]
5. Structural and functional observations of the P151L MID1 mutation reveal alpha4 plays a significant role in X-linked Opitz Syndrome.
Wright KM; Du H; Massiah MA
FEBS J; 2017 Jul; 284(14):2183-2193. PubMed ID: 28548391
[TBL] [Abstract][Full Text] [Related]
6. The MID1 E3 ligase catalyzes the polyubiquitination of Alpha4 (α4), a regulatory subunit of protein phosphatase 2A (PP2A): novel insights into MID1-mediated regulation of PP2A.
Du H; Huang Y; Zaghlula M; Walters E; Cox TC; Massiah MA
J Biol Chem; 2013 Jul; 288(29):21341-21350. PubMed ID: 23740247
[TBL] [Abstract][Full Text] [Related]
7. Active transport of the ubiquitin ligase MID1 along the microtubules is regulated by protein phosphatase 2A.
Aranda-Orgillés B; Aigner J; Kunath M; Lurz R; Schneider R; Schweiger S
PLoS One; 2008; 3(10):e3507. PubMed ID: 18949047
[TBL] [Abstract][Full Text] [Related]
8. X-linked Opitz syndrome: novel mutations in the MID1 gene and redefinition of the clinical spectrum.
De Falco F; Cainarca S; Andolfi G; Ferrentino R; Berti C; Rodríguez Criado G; Rittinger O; Dennis N; Odent S; Rastogi A; Liebelt J; Chitayat D; Winter R; Jawanda H; Ballabio A; Franco B; Meroni G
Am J Med Genet A; 2003 Jul; 120A(2):222-8. PubMed ID: 12833403
[TBL] [Abstract][Full Text] [Related]
9. Detection and characterization of the in vitro e3 ligase activity of the human MID1 protein.
Han X; Du H; Massiah MA
J Mol Biol; 2011 Apr; 407(4):505-20. PubMed ID: 21296087
[TBL] [Abstract][Full Text] [Related]
10. MID1, mutated in Opitz syndrome, encodes an ubiquitin ligase that targets phosphatase 2A for degradation.
Trockenbacher A; Suckow V; Foerster J; Winter J; Krauss S; Ropers HH; Schneider R; Schweiger S
Nat Genet; 2001 Nov; 29(3):287-94. PubMed ID: 11685209
[TBL] [Abstract][Full Text] [Related]
11. Control of mTORC1 signaling by the Opitz syndrome protein MID1.
Liu E; Knutzen CA; Krauss S; Schweiger S; Chiang GG
Proc Natl Acad Sci U S A; 2011 May; 108(21):8680-5. PubMed ID: 21555591
[TBL] [Abstract][Full Text] [Related]
12. The E3 ubiquitin ligase- and protein phosphatase 2A (PP2A)-binding domains of the Alpha4 protein are both required for Alpha4 to inhibit PP2A degradation.
LeNoue-Newton M; Watkins GR; Zou P; Germane KL; McCorvey LR; Wadzinski BE; Spiller BW
J Biol Chem; 2011 May; 286(20):17665-71. PubMed ID: 21454489
[TBL] [Abstract][Full Text] [Related]
13. Phosphorylation and microtubule association of the Opitz syndrome protein mid-1 is regulated by protein phosphatase 2A via binding to the regulatory subunit alpha 4.
Liu J; Prickett TD; Elliott E; Meroni G; Brautigan DL
Proc Natl Acad Sci U S A; 2001 Jun; 98(12):6650-5. PubMed ID: 11371618
[TBL] [Abstract][Full Text] [Related]
14. Mechanism of midline defect-causing mutation P151L in MID1 revealed.
Nicholson LK
FEBS J; 2017 Jul; 284(14):2167-2169. PubMed ID: 28714291
[TBL] [Abstract][Full Text] [Related]
15. A unique missense mutation in the RING domain impairs MID1 E3 ubiquitin ligase activity and localisation and is associated with uncommon Opitz Syndrome-like signs.
Mascaro M; D'Ambrosio L; Lazzari E; Almoguera B; Swafiri ST; Zanchetta ME; Meroni G
Biochim Biophys Acta Mol Basis Dis; 2024 Apr; 1870(4):167126. PubMed ID: 38508475
[No Abstract] [Full Text] [Related]
16. A structure-function study of MID1 mutations associated with a mild Opitz phenotype.
Mnayer L; Khuri S; Merheby HA; Meroni G; Elsas LJ
Mol Genet Metab; 2006 Mar; 87(3):198-203. PubMed ID: 16378742
[TBL] [Abstract][Full Text] [Related]
17. The Opitz syndrome gene product, MID1, associates with microtubules.
Schweiger S; Foerster J; Lehmann T; Suckow V; Muller YA; Walter G; Davies T; Porter H; van Bokhoven H; Lunt PW; Traub P; Ropers HH
Proc Natl Acad Sci U S A; 1999 Mar; 96(6):2794-9. PubMed ID: 10077590
[TBL] [Abstract][Full Text] [Related]
18. The Opitz syndrome gene product MID1 assembles a microtubule-associated ribonucleoprotein complex.
Aranda-Orgillés B; Trockenbacher A; Winter J; Aigner J; Köhler A; Jastrzebska E; Stahl J; Müller EC; Otto A; Wanker EE; Schneider R; Schweiger S
Hum Genet; 2008 Mar; 123(2):163-76. PubMed ID: 18172692
[TBL] [Abstract][Full Text] [Related]
19. MID1 and MID2 homo- and heterodimerise to tether the rapamycin-sensitive PP2A regulatory subunit, alpha 4, to microtubules: implications for the clinical variability of X-linked Opitz GBBB syndrome and other developmental disorders.
Short KM; Hopwood B; Yi Z; Cox TC
BMC Cell Biol; 2002; 3():1. PubMed ID: 11806752
[TBL] [Abstract][Full Text] [Related]
20. Emerging Roles of the TRIM E3 Ubiquitin Ligases MID1 and MID2 in Cytokinesis.
Zanchetta ME; Meroni G
Front Physiol; 2019; 10():274. PubMed ID: 30941058
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
